For the treatment of both seasonal allergic rhinitis (e.g. hayfever) and perennial allergic rhinitis in patients aged 6 years and over.
The FDA has approved Noctiva (desmopressin acetate) nasal spray from Serenity Pharmaceuticals for adults who awaken at least two times...
Impel NeuroPharma, Inc. announced that the FDA approved Trudhesa (dihydroergotamine mesylate) nasal spray (0.725 mg per spray) for the acute treatment of migraine with or without aura in adults. Trudhesa was previously known as INP 104.
The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the European Commission (EC) has approved Spravato (esketamine) nasal spray,...
The EC has authorised SPRAVATO (esketamine) nasal spray in combination with a selective serotonin reuptake inhibitor or serotonin and norepinephrine reuptake inhibitor.